Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27011372)
Watch
English
Myelodysplastic syndromes: what do hospitalists need to know?
scientific article
In more languages
edit
Statements
instance of
scholarly article
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
title
Myelodysplastic syndromes: what do hospitalists need to know?
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
author
Bishoy Faltas
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
author name string
Steven Gore
series ordinal
4
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
Amer M Zeidan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
B Douglas Smith
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
11 May 2013
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
published in
Journal of Hospital Medicine
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
volume
8
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
issue
6
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
page(s)
351-357
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
cites work
Epidemiology of myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
International scoring system for evaluating prognosis in myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
Proposals for the classification of the myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
21 March 2017
Interpreting new molecular genetics in myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Myelodysplastic syndromes: who and when in the course of disease to transplant
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Revised international prognostic scoring system for myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Updates in cytogenetics and molecular markers in MDS.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Unraveling the molecular pathophysiology of myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 September 2017
Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
31 May 2018
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
31 May 2018
Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
31 May 2018
Why are myelodysplastic syndromes unrecognized and underdiagnosed? A primary care perspective
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234094
retrieved
28 November 2018
'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Myelodysplastic syndromes: incidence and survival in the United States
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Hematopoietic growth factors in myelodysplastic syndromes
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Myelodysplastic syndromes: increasing disease awareness. Introduction
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Myelodysplastic syndromes: increasing disease awareness. Discussion
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23666619
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1002/JHM.2049
1 reference
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
PMC publication ID
4234094
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
PubMed publication ID
23666619
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4234094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666619%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit